2,5-di-tert-butylhydroquinone and Leukemia, T-Cell

2,5-di-tert-butylhydroquinone has been researched along with Leukemia, T-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chow, SB; Gahm, A; Kass, GE; Llopis, J; Orrenius, S1

Other Studies

1 other study(ies) available for 2,5-di-tert-butylhydroquinone and Leukemia, T-Cell

ArticleYear
Comparison between the effects of the microsomal Ca(2+)-translocase inhibitors thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone on cellular calcium fluxes.
    The Biochemical journal, 1991, Jul-15, Volume: 277 ( Pt 2)

    Topics: Animals; Antioxidants; Calcium; Calcium-Transporting ATPases; Cell Line; Cells, Cultured; Cytosol; Fura-2; Humans; Hydroquinones; Kinetics; Leukemia, T-Cell; Liver; Male; Microsomes, Liver; Rats; Rats, Inbred Strains; Signal Transduction; Terpenes; Thapsigargin; Vasopressins

1991